{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:54:45Z","timestamp":1790636085382,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068614"],"award-info":[{"award-number":["UM1 AI068614"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068635"],"award-info":[{"award-number":["UM1 AI068635"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI068618"],"award-info":[{"award-number":["UM1 AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI069470"],"award-info":[{"award-number":["UM1 AI069470"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI069534"],"award-info":[{"award-number":["UM1 AI069534"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI069511"],"award-info":[{"award-number":["UM1 AI069511"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI069439"],"award-info":[{"award-number":["UM1 AI069439"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NO1-AI-80061"],"award-info":[{"award-number":["NO1-AI-80061"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NO1-AI-80062"],"award-info":[{"award-number":["NO1-AI-80062"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202753","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T17:35:04Z","timestamp":1537464904000},"page":"e0202753","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-1530","authenticated-orcid":true,"given":"Marnie L.","family":"Elizaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi K.","family":"Kochar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-0714","authenticated-orcid":true,"given":"Mary A.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Van N.","family":"Tieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena E.","family":"Sobieszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen W.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Latham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Eldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Ota-Setlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Mhorag","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"issue":"Pt 21","key":"ref1","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jeb.00642","article-title":"Prime-boost strategies for malaria vaccine development","volume":"206","author":"SJ Dunachie","year":"2003","journal-title":"J Exp Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T cells using heterologous prime-boost immunisation strategies","volume":"170","author":"J Schneider","year":"1999","journal-title":"Immunol Rev"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2009.025","article-title":"Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo","volume":"20","author":"KA Kraynyak","year":"2009","journal-title":"Hum Gene Ther"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/17425247.2016.1121990","article-title":"Clinical potential of electroporation for gene therapy and DNA vaccine delivery","volume":"13","author":"L Lambricht","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"issue":"51","key":"ref5","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2016.06.071","article-title":"Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk\/benefit assessment","volume":"34","author":"DK Clarke","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-006-0042-3","article-title":"Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector","volume":"28","author":"DK Clarke","year":"2006","journal-title":"Springer Semin Immunopathol"},{"issue":"6179","key":"ref7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1250672","article-title":"Immunology. Immune activation with HIV vaccines","volume":"344","author":"AS Fauci","year":"2014","journal-title":"Science"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"ofv082","DOI":"10.1093\/ofid\/ofv082","article-title":"First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)","volume":"2","author":"JD Fuchs","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"17","key":"ref9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe","volume":"374","author":"ST Agnandji","year":"2016","journal-title":"N Engl J Med"},{"issue":"9996","key":"ref10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"AM Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"ref11","article-title":"A Recombinant Vesicular Stomatitis Virus Ebola Vaccine\u2014Preliminary Report","author":"JA Regules","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"A Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2004.01.015","article-title":"Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines","volume":"110","author":"S Babiuk","year":"2004","journal-title":"J Biotechnol"},{"issue":"27\u201328","key":"ref14","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1016\/S0264-410X(02)00269-4","article-title":"Electroporation improves the efficacy of DNA vaccines in large animals","volume":"20","author":"S Babiuk","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3495(90)82348-1","article-title":"Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy","volume":"58","author":"DC Chang","year":"1990","journal-title":"Biophys J"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/156652311798192860","article-title":"Plasmid DNA gene therapy by electroporation: principles and recent advances","volume":"11","author":"T Murakami","year":"2011","journal-title":"Curr Gene Ther"},{"key":"ref17","first-page":"491","article-title":"Gene transfer by electroporation: a model for gene therapy","volume":"333","author":"A Keating","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"8","key":"ref18","first-page":"16","article-title":"Electroporation: an effective technique for drug delivery and gene therapy","volume":"11","author":"C Featherstone","year":"1993","journal-title":"Am Biotechnol Lab"},{"key":"ref19","first-page":"273","article-title":"Electroporation for gene therapy","volume":"48","author":"KE Matthews","year":"1995","journal-title":"Methods Mol Biol"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nbt0998-867","article-title":"Gene transfer into muscle by electroporation in vivo","volume":"16","author":"H Aihara","year":"1998","journal-title":"Nat Biotechnol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/156652310791823489","article-title":"Electroporation gene therapy preclinical and clinical trials for melanoma","volume":"10","author":"LC Heller","year":"2010","journal-title":"Curr Gene Ther"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.0902371","article-title":"IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors","volume":"184","author":"S Zhu","year":"2010","journal-title":"J Immunol"},{"key":"ref23","first-page":"736","article-title":"Electroporation based gene therapy\u2014from the bench to the bedside","volume":"2011","author":"R Heller","year":"2011","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"e19252","DOI":"10.1371\/journal.pone.0019252","article-title":"In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers","volume":"6","author":"S Vasan","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.vaccine.2010.11.011","article-title":"Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation","volume":"29","author":"KE Dolter","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"SA Kalams","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"13011","DOI":"10.1038\/s41598-017-13331-1","article-title":"Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trial","volume":"7","author":"G Haidari","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"ref28","first-page":"1005","article-title":"Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model","volume":"61","author":"YI Yamashita","year":"2001","journal-title":"Cancer Res"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/aid.2005.21.629","article-title":"Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus","volume":"21","author":"MA Egan","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5144","key":"ref30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"LC Afonso","year":"1994","journal-title":"Science"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"e29231","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"SA Kalams","year":"2012","journal-title":"PLoS ONE"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.4049\/jimmunol.162.11.6724","article-title":"IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner","volume":"162","author":"MM Gherardi","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/10799900050044787","article-title":"Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses","volume":"20","author":"K Lee","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"ref34","article-title":"DNA priming increases frequency of T-cell responses to a VSV HIV vaccine with specific enhancement of CD8+ T-cell responses by IL-12 pDNA","author":"SS Li","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"21","key":"ref35","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1016\/j.vaccine.2005.08.024","article-title":"Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice","volume":"24","author":"MA Egan","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"e0134287","DOI":"10.1371\/journal.pone.0134287","article-title":"A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults","volume":"10","author":"J Mpendo","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.01515-07","article-title":"Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice","volume":"82","author":"D Cooper","year":"2008","journal-title":"J Virol"},{"issue":"Suppl 1","key":"ref38","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/s00586-005-1044-x","article-title":"Pain assessment","volume":"15","author":"M Haefeli","year":"2006","journal-title":"Eur Spine J"},{"issue":"3","key":"ref39","first-page":"189","article-title":"Mini-Mental State\u2014Practical Method for Grading Cognitive State of Patients for Clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"67","key":"ref40","first-page":"e4302","article-title":"Enumeration of major peripheral blood leukocyte populations for multicenter clinical trials using a whole blood phenotyping assay","author":"TR Hensley","year":"2012","journal-title":"J Vis Exp"},{"key":"ref41","article-title":"Optimization of a whole blood phenotyping assay for enumeration of peripheral blood leukocyte populations in multicenter clinical trials","author":"T Hensley-McBain","year":"2014","journal-title":"J Immunol Methods"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"NM Laird","year":"1982","journal-title":"Biometrics"},{"key":"ref43","article-title":"Merck Ad5\/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity","author":"D Zak","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/infdis\/143.2.252","article-title":"The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes","volume":"143","author":"GB Faguet","year":"1981","journal-title":"J Infect Dis"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"e0157385","DOI":"10.1371\/journal.pone.0157385","article-title":"Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review","volume":"11","author":"V Muturi-Kioi","year":"2016","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T08:04:26Z","timestamp":1693901066000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202753"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202753","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]}}}